

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 8.81302020 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 8.17342923 |
| 3 | neutral lipid catabolic process (GO:0046461) | 7.93755375 |
| 4 | acylglycerol catabolic process (GO:0046464) | 7.93755375 |
| 5 | white fat cell differentiation (GO:0050872) | 7.46997368 |
| 6 | brown fat cell differentiation (GO:0050873) | 6.88150790 |
| 7 | lipid particle organization (GO:0034389) | 6.45021536 |
| 8 | valine metabolic process (GO:0006573) | 6.30396625 |
| 9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.29037569 |
| 10 | regulation of cholesterol storage (GO:0010885) | 6.13479365 |
| 11 | glycerolipid catabolic process (GO:0046503) | 5.96043218 |
| 12 | triglyceride biosynthetic process (GO:0019432) | 5.92573851 |
| 13 | biotin metabolic process (GO:0006768) | 5.82776519 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 5.81653909 |
| 15 | neutral lipid biosynthetic process (GO:0046460) | 5.68399933 |
| 16 | acylglycerol biosynthetic process (GO:0046463) | 5.68399933 |
| 17 | fatty acid transmembrane transport (GO:1902001) | 5.67234692 |
| 18 | lipid storage (GO:0019915) | 5.44900262 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.31078729 |
| 20 | polyol transport (GO:0015791) | 4.81466924 |
| 21 | triglyceride metabolic process (GO:0006641) | 4.78011146 |
| 22 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.70894833 |
| 23 | plasma lipoprotein particle clearance (GO:0034381) | 4.65542957 |
| 24 | fatty acid homeostasis (GO:0055089) | 4.59212132 |
| 25 | protein heterotrimerization (GO:0070208) | 4.57489240 |
| 26 | acylglycerol metabolic process (GO:0006639) | 4.53109086 |
| 27 | * fatty acid beta-oxidation (GO:0006635) | 4.52961755 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.52116648 |
| 29 | carnitine shuttle (GO:0006853) | 4.50697711 |
| 30 | neutral lipid metabolic process (GO:0006638) | 4.47122603 |
| 31 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.46728971 |
| 32 | negative regulation of protein autophosphorylation (GO:0031953) | 4.39342360 |
| 33 | ethanol oxidation (GO:0006069) | 4.38541015 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37549874 |
| 35 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.26969946 |
| 36 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.26213793 |
| 37 | regulation of fatty acid oxidation (GO:0046320) | 4.24761758 |
| 38 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.24722137 |
| 39 | positive regulation of lipid catabolic process (GO:0050996) | 4.23774008 |
| 40 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.20875143 |
| 41 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.17389281 |
| 42 | negative regulation of smooth muscle cell migration (GO:0014912) | 4.15791031 |
| 43 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.13611729 |
| 44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.13611729 |
| 45 | branched-chain amino acid metabolic process (GO:0009081) | 4.11569592 |
| 46 | L-serine transport (GO:0015825) | 4.10227078 |
| 47 | thioester biosynthetic process (GO:0035384) | 4.08932164 |
| 48 | acyl-CoA biosynthetic process (GO:0071616) | 4.08932164 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 4.06526855 |
| 50 | positive regulation of lipid storage (GO:0010884) | 4.04943480 |
| 51 | positive regulation of glucose import (GO:0046326) | 4.03665412 |
| 52 | * fatty acid oxidation (GO:0019395) | 4.02270440 |
| 53 | negative regulation of metanephros development (GO:0072217) | 4.01236951 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.98880721 |
| 55 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.98640079 |
| 56 | positive regulation of glycolytic process (GO:0045821) | 3.97675491 |
| 57 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.96448708 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 3.96021219 |
| 59 | * lipid oxidation (GO:0034440) | 3.94645427 |
| 60 | * fatty acid catabolic process (GO:0009062) | 3.89847202 |
| 61 | primary alcohol metabolic process (GO:0034308) | 3.84027044 |
| 62 | response to phenylpropanoid (GO:0080184) | 3.83491724 |
| 63 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.83459151 |
| 64 | positive regulation of glomerulus development (GO:0090193) | 3.83420678 |
| 65 | cellular response to lithium ion (GO:0071285) | 3.78651615 |
| 66 | coenzyme A biosynthetic process (GO:0015937) | 3.78559741 |
| 67 | cGMP-mediated signaling (GO:0019934) | 3.78410497 |
| 68 | pentose-phosphate shunt (GO:0006098) | 3.76953537 |
| 69 | positive regulation of cholesterol efflux (GO:0010875) | 3.75939971 |
| 70 | branched-chain amino acid catabolic process (GO:0009083) | 3.75835654 |
| 71 | carnitine transmembrane transport (GO:1902603) | 3.74399002 |
| 72 | growth hormone receptor signaling pathway (GO:0060396) | 3.73892715 |
| 73 | response to epinephrine (GO:0071871) | 3.71758397 |
| 74 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.71360038 |
| 75 | NADPH regeneration (GO:0006740) | 3.70025600 |
| 76 | retinol metabolic process (GO:0042572) | 3.69442537 |
| 77 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.68774867 |
| 78 | positive regulation of cholesterol transport (GO:0032376) | 3.66485571 |
| 79 | positive regulation of sterol transport (GO:0032373) | 3.66485571 |
| 80 | protein localization to cell surface (GO:0034394) | 3.65496661 |
| 81 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.64668805 |
| 82 | endocrine hormone secretion (GO:0060986) | 3.63233956 |
| 83 | negative regulation of lipid storage (GO:0010888) | 3.63001553 |
| 84 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.61755561 |
| 85 | oxaloacetate metabolic process (GO:0006107) | 3.61063885 |
| 86 | regulation of receptor binding (GO:1900120) | 3.55513533 |
| 87 | serine transport (GO:0032329) | 3.53937208 |
| 88 | alanine transport (GO:0032328) | 3.53685800 |
| 89 | barbed-end actin filament capping (GO:0051016) | 3.51101882 |
| 90 | keratan sulfate catabolic process (GO:0042340) | 3.50990098 |
| 91 | phosphatidic acid biosynthetic process (GO:0006654) | 3.50544398 |
| 92 | phosphatidic acid metabolic process (GO:0046473) | 3.50544398 |
| 93 | triglyceride homeostasis (GO:0070328) | 3.50455728 |
| 94 | acylglycerol homeostasis (GO:0055090) | 3.50455728 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 3.49555104 |
| 96 | negative regulation of macrophage differentiation (GO:0045650) | 3.48182960 |
| 97 | angiogenesis involved in wound healing (GO:0060055) | 3.45092186 |
| 98 | positive regulation of metanephros development (GO:0072216) | 3.44542436 |
| 99 | tricarboxylic acid metabolic process (GO:0072350) | 3.44048299 |
| 100 | amino-acid betaine transport (GO:0015838) | 3.43540246 |
| 101 | carnitine transport (GO:0015879) | 3.43540246 |
| 102 | positive regulation of macrophage cytokine production (GO:0060907) | 3.42857840 |
| 103 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.42844391 |
| 104 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.41033796 |
| 105 | positive regulation of glucose transport (GO:0010828) | 3.39577743 |
| 106 | transcytosis (GO:0045056) | 3.39008161 |
| 107 | glomerular filtration (GO:0003094) | 3.38733278 |
| 108 | acetyl-CoA metabolic process (GO:0006084) | 3.38531922 |
| 109 | regulation of lipid storage (GO:0010883) | 3.37884358 |
| 110 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.33690005 |
| 111 | regulation of glomerulus development (GO:0090192) | 3.33380931 |
| 112 | regulation of triglyceride catabolic process (GO:0010896) | 3.32482442 |
| 113 | renal filtration (GO:0097205) | 3.31324877 |
| 114 | phagocytosis, recognition (GO:0006910) | 3.30548946 |
| 115 | regulation of macrophage chemotaxis (GO:0010758) | 3.30113195 |
| 116 | endothelium development (GO:0003158) | 3.29759014 |
| 117 | import into cell (GO:0098657) | 3.29118288 |
| 118 | NADH metabolic process (GO:0006734) | 3.29100036 |
| 119 | ethanol metabolic process (GO:0006067) | 3.27305526 |
| 120 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.27247886 |
| 121 | long-chain fatty acid transport (GO:0015909) | 3.26633836 |
| 122 | negative regulation of gluconeogenesis (GO:0045721) | 3.25721046 |
| 123 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.25174269 |
| 124 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24685348 |
| 125 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.24597228 |
| 126 | response to hydroperoxide (GO:0033194) | 3.22713880 |
| 127 | cellular response to growth hormone stimulus (GO:0071378) | 3.22066230 |
| 128 | polyketide metabolic process (GO:0030638) | 3.20759893 |
| 129 | doxorubicin metabolic process (GO:0044598) | 3.20759893 |
| 130 | daunorubicin metabolic process (GO:0044597) | 3.20759893 |
| 131 | apoptotic cell clearance (GO:0043277) | 3.19959542 |
| 132 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.19148757 |
| 133 | regulation of protein kinase A signaling (GO:0010738) | 3.12795646 |
| 134 | negative regulation of lipid catabolic process (GO:0050995) | 3.11122520 |
| 135 | endothelial cell morphogenesis (GO:0001886) | 3.10071694 |
| 136 | extracellular fibril organization (GO:0043206) | 3.08379252 |
| 137 | lipoprotein transport (GO:0042953) | 3.03753401 |
| 138 | primary alcohol catabolic process (GO:0034310) | 2.97837814 |
| 139 | regulation of lipid catabolic process (GO:0050994) | 2.93401051 |
| 140 | low-density lipoprotein particle clearance (GO:0034383) | 10.8821150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.42670166 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.76600513 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.72337017 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71462551 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69915835 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64510377 |
| 7 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.53686114 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43390114 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29503221 |
| 10 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.12903155 |
| 11 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 14.3748407 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96771950 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91163479 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91131870 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89219042 |
| 16 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86674525 |
| 17 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.81031975 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75314552 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73419472 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72341563 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55378811 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55059334 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.49528819 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43254401 |
| 25 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43057637 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32356325 |
| 27 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30541942 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30195165 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29953235 |
| 30 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.28553896 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27323404 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27323404 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26359600 |
| 34 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.23139381 |
| 35 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18187054 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17453687 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16976110 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15375170 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14791505 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14487160 |
| 41 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14443326 |
| 42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13745796 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13399430 |
| 44 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.13178644 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11746049 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11589197 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10648872 |
| 48 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09670425 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09656181 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08683687 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07150636 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04829531 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01317871 |
| 54 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00694592 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00597984 |
| 56 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00117994 |
| 57 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99981575 |
| 58 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98756771 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97874319 |
| 60 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97562116 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96115556 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95385310 |
| 63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95385310 |
| 64 | CBP_21632823_ChIP-Seq_H3396_Human | 0.95313831 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94960020 |
| 66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94654994 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94458638 |
| 68 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94089565 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93758417 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93594820 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93567868 |
| 72 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91605452 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89724383 |
| 74 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89632636 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86186396 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84262421 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83863261 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83269433 |
| 79 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.82507726 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82501157 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82501157 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82153448 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82088904 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82026128 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81758386 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81661850 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81257296 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80690832 |
| 89 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.80357178 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.78769037 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78416611 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77370834 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76333045 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74776228 |
| 95 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74645795 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.74131693 |
| 97 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74038486 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74025811 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73717565 |
| 100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.73314520 |
| 101 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.72751683 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71871737 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.71696350 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71696136 |
| 105 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.70260597 |
| 106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69507339 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69035724 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 0.68416808 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.68215717 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68103398 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.67911434 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67766005 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67706770 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.67402740 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.67211832 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67051829 |
| 117 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.66597783 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65751915 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.65445255 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.64932613 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.64750031 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64734021 |
| 123 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.64336499 |
| 124 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.64191729 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.64184639 |
| 126 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.64065257 |
| 127 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63373605 |
| 128 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63302598 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63210429 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.63167382 |
| 131 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62812922 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.62497122 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61348522 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.60868065 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60612806 |
| 136 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.59896887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.43278785 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.68341577 |
| 3 | MP0004130_abnormal_muscle_cell | 5.07070555 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 4.98892758 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 4.71105212 |
| 6 | * MP0005375_adipose_tissue_phenotype | 4.00991784 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.92423212 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.25865678 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.25091551 |
| 10 | MP0005275_abnormal_skin_tensile | 3.20217493 |
| 11 | MP0002971_abnormal_brown_adipose | 3.05165659 |
| 12 | MP0005503_abnormal_tendon_morphology | 3.01754698 |
| 13 | * MP0010329_abnormal_lipoprotein_level | 2.70189656 |
| 14 | MP0005334_abnormal_fat_pad | 2.55319548 |
| 15 | * MP0009115_abnormal_fat_cell | 2.55204153 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.30341367 |
| 17 | * MP0000003_abnormal_adipose_tissue | 2.29880385 |
| 18 | MP0004272_abnormal_basement_membrane | 2.02902036 |
| 19 | * MP0002970_abnormal_white_adipose | 2.02716514 |
| 20 | * MP0002118_abnormal_lipid_homeostasis | 1.99343813 |
| 21 | MP0005535_abnormal_body_temperature | 1.98393801 |
| 22 | * MP0002876_abnormal_thyroid_physiology | 1.91242538 |
| 23 | MP0001661_extended_life_span | 1.91168696 |
| 24 | MP0003868_abnormal_feces_composition | 1.79392115 |
| 25 | MP0003724_increased_susceptibility_to | 1.67441755 |
| 26 | MP0005448_abnormal_energy_balance | 1.55010398 |
| 27 | * MP0003959_abnormal_lean_body | 1.43363071 |
| 28 | MP0005365_abnormal_bile_salt | 1.35886145 |
| 29 | * MP0003690_abnormal_glial_cell | 1.32601060 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.31431028 |
| 31 | MP0004147_increased_porphyrin_level | 1.30541062 |
| 32 | MP0002933_joint_inflammation | 1.30401846 |
| 33 | MP0000751_myopathy | 1.28797971 |
| 34 | * MP0005452_abnormal_adipose_tissue | 1.28717226 |
| 35 | MP0001727_abnormal_embryo_implantation | 1.28626530 |
| 36 | MP0003828_pulmonary_edema | 1.23922060 |
| 37 | * MP0000609_abnormal_liver_physiology | 1.23897675 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 1.22967267 |
| 39 | MP0001881_abnormal_mammary_gland | 1.20857049 |
| 40 | * MP0002108_abnormal_muscle_morphology | 1.20073013 |
| 41 | MP0002254_reproductive_system_inflammat | 1.19749208 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.17602525 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.15211688 |
| 44 | MP0006138_congestive_heart_failure | 1.14013691 |
| 45 | MP0002060_abnormal_skin_morphology | 1.12743652 |
| 46 | MP0002796_impaired_skin_barrier | 1.12591870 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.12172694 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.12158294 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.10386514 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.07306222 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.06952066 |
| 52 | MP0003045_fibrosis | 1.06817535 |
| 53 | MP0000343_altered_response_to | 1.02400649 |
| 54 | MP0008775_abnormal_heart_ventricle | 0.99586715 |
| 55 | MP0001756_abnormal_urination | 0.96647727 |
| 56 | * MP0003186_abnormal_redox_activity | 0.93853653 |
| 57 | MP0000767_abnormal_smooth_muscle | 0.92083124 |
| 58 | MP0008961_abnormal_basal_metabolism | 0.82589541 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.82577568 |
| 60 | MP0002006_tumorigenesis | 0.82062627 |
| 61 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80480520 |
| 62 | MP0002168_other_aberrant_phenotype | 0.78707546 |
| 63 | MP0005164_abnormal_response_to | 0.78049026 |
| 64 | MP0002332_abnormal_exercise_endurance | 0.76216381 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.75980305 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 0.74215928 |
| 67 | MP0001177_atelectasis | 0.73870713 |
| 68 | MP0005508_abnormal_skeleton_morphology | 0.73360242 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.72727642 |
| 70 | MP0005360_urolithiasis | 0.72277625 |
| 71 | * MP0005620_abnormal_muscle_contractility | 0.71570892 |
| 72 | * MP0000759_abnormal_skeletal_muscle | 0.70322540 |
| 73 | MP0001958_emphysema | 0.69860814 |
| 74 | * MP0001544_abnormal_cardiovascular_syste | 0.69841019 |
| 75 | * MP0005385_cardiovascular_system_phenoty | 0.69841019 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.68925971 |
| 77 | * MP0004087_abnormal_muscle_fiber | 0.66534145 |
| 78 | * MP0003948_abnormal_gas_homeostasis | 0.66289680 |
| 79 | * MP0003953_abnormal_hormone_level | 0.66143104 |
| 80 | MP0000749_muscle_degeneration | 0.65474255 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.65177298 |
| 82 | MP0004084_abnormal_cardiac_muscle | 0.63310860 |
| 83 | MP0000427_abnormal_hair_cycle | 0.62526372 |
| 84 | MP0005388_respiratory_system_phenotype | 0.62305380 |
| 85 | MP0002133_abnormal_respiratory_system | 0.62305380 |
| 86 | MP0009763_increased_sensitivity_to | 0.61915050 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.61376453 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.61167543 |
| 89 | MP0009672_abnormal_birth_weight | 0.60986053 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.59218947 |
| 91 | MP0005165_increased_susceptibility_to | 0.59175287 |
| 92 | MP0000249_abnormal_blood_vessel | 0.58492273 |
| 93 | * MP0009643_abnormal_urine_homeostasis | 0.57743451 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.55825078 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.54696192 |
| 96 | MP0001542_abnormal_bone_strength | 0.53929474 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.51620730 |
| 98 | MP0000747_muscle_weakness | 0.51255058 |
| 99 | MP0003448_altered_tumor_morphology | 0.50301140 |
| 100 | MP0005390_skeleton_phenotype | 0.50190713 |
| 101 | MP0003646_muscle_fatigue | 0.49758930 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.48963802 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.48911782 |
| 104 | MP0002128_abnormal_blood_circulation | 0.48728035 |
| 105 | MP0005332_abnormal_amino_acid | 0.48506736 |
| 106 | MP0003075_altered_response_to | 0.48329950 |
| 107 | MP0005023_abnormal_wound_healing | 0.47857447 |
| 108 | MP0003279_aneurysm | 0.46331135 |
| 109 | * MP0006036_abnormal_mitochondrial_physio | 0.45773704 |
| 110 | MP0000604_amyloidosis | 0.45537397 |
| 111 | MP0004858_abnormal_nervous_system | 0.45236645 |
| 112 | MP0002090_abnormal_vision | 0.45192434 |
| 113 | MP0003011_delayed_dark_adaptation | 0.44884663 |
| 114 | * MP0001614_abnormal_blood_vessel | 0.44102518 |
| 115 | MP0005647_abnormal_sex_gland | 0.43992109 |
| 116 | MP0004883_abnormal_blood_vessel | 0.43336826 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.43073881 |
| 118 | MP0003091_abnormal_cell_migration | 0.43056312 |
| 119 | MP0005330_cardiomyopathy | 0.43038832 |
| 120 | * MP0001501_abnormal_sleep_pattern | 0.43002146 |
| 121 | MP0001851_eye_inflammation | 0.41799342 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.41682685 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.41682685 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.41606806 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41069999 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.40854134 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.39362482 |
| 128 | MP0005501_abnormal_skin_physiology | 0.38322292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.62845774 |
| 2 | Acanthosis nigricans (HP:0000956) | 7.73316845 |
| 3 | Hypertriglyceridemia (HP:0002155) | 6.70971634 |
| 4 | Hyperglycinuria (HP:0003108) | 5.34556963 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 4.33317363 |
| 6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33317363 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.29907216 |
| 8 | Difficulty running (HP:0009046) | 4.11145767 |
| 9 | Pigmentary retinal degeneration (HP:0001146) | 3.96568627 |
| 10 | Increased connective tissue (HP:0009025) | 3.96303815 |
| 11 | Long foot (HP:0001833) | 3.92473585 |
| 12 | Complement deficiency (HP:0004431) | 3.81311063 |
| 13 | Epidermoid cyst (HP:0200040) | 3.66837725 |
| 14 | Hemorrhage of the eye (HP:0011885) | 3.66006919 |
| 15 | Insulin resistance (HP:0000855) | 3.59893136 |
| 16 | Back pain (HP:0003418) | 3.59099852 |
| 17 | Subcapsular cataract (HP:0000523) | 3.50019222 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.42317935 |
| 19 | Abnormality of proline metabolism (HP:0010907) | 3.41394517 |
| 20 | Hydroxyprolinuria (HP:0003080) | 3.41394517 |
| 21 | Myoglobinuria (HP:0002913) | 3.40137123 |
| 22 | Growth hormone excess (HP:0000845) | 3.39463248 |
| 23 | Myocardial infarction (HP:0001658) | 3.34567566 |
| 24 | Hyperthyroidism (HP:0000836) | 3.33140682 |
| 25 | Bone cyst (HP:0012062) | 3.32017729 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.26374574 |
| 27 | Thyroid-stimulating hormone excess (HP:0002925) | 3.18224375 |
| 28 | Multiple enchondromatosis (HP:0005701) | 3.17439357 |
| 29 | Polycythemia (HP:0001901) | 3.14358053 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.13804568 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11205421 |
| 32 | Ectopia lentis (HP:0001083) | 3.08367021 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.05743203 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.04297890 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.03403009 |
| 36 | Cerebral aneurysm (HP:0004944) | 3.01797931 |
| 37 | Large hands (HP:0001176) | 2.96696633 |
| 38 | Cervical subluxation (HP:0003308) | 2.96478864 |
| 39 | Ankle contracture (HP:0006466) | 2.92235857 |
| 40 | Hyperpituitarism (HP:0010514) | 2.87298468 |
| 41 | Xanthomatosis (HP:0000991) | 2.85658858 |
| 42 | Colitis (HP:0002583) | 2.85596294 |
| 43 | Broad metatarsal (HP:0001783) | 2.83509951 |
| 44 | Frequent falls (HP:0002359) | 2.83428730 |
| 45 | Skin nodule (HP:0200036) | 2.80139145 |
| 46 | Ketoacidosis (HP:0001993) | 2.77176757 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.76835120 |
| 48 | Muscle fiber splitting (HP:0003555) | 2.72001115 |
| 49 | Abnormality of complement system (HP:0005339) | 2.71429582 |
| 50 | Spinal rigidity (HP:0003306) | 2.71206427 |
| 51 | Testicular atrophy (HP:0000029) | 2.70231249 |
| 52 | Ketosis (HP:0001946) | 2.69572136 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.64197308 |
| 54 | Nausea (HP:0002018) | 2.59249313 |
| 55 | Rhabdomyolysis (HP:0003201) | 2.56966079 |
| 56 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54720999 |
| 57 | Facial diplegia (HP:0001349) | 2.53682333 |
| 58 | Premature rupture of membranes (HP:0001788) | 2.51940814 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.49955271 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.47673920 |
| 61 | Pancreatitis (HP:0001733) | 2.42692623 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.42074365 |
| 63 | Lipoatrophy (HP:0100578) | 2.40400558 |
| 64 | Axonal loss (HP:0003447) | 2.38696111 |
| 65 | Lymphangioma (HP:0100764) | 2.38361262 |
| 66 | Accelerated skeletal maturation (HP:0005616) | 2.37920172 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.36968884 |
| 68 | Follicular hyperkeratosis (HP:0007502) | 2.36654117 |
| 69 | Hyperglycinemia (HP:0002154) | 2.34709423 |
| 70 | Vascular tortuosity (HP:0004948) | 2.33813363 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33238648 |
| 72 | Tetraparesis (HP:0002273) | 2.31436432 |
| 73 | Metaphyseal dysplasia (HP:0100255) | 2.29827392 |
| 74 | Amyloidosis (HP:0011034) | 2.26125671 |
| 75 | Prenatal maternal abnormality (HP:0002686) | 2.25019788 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.24657988 |
| 77 | Gonadotropin excess (HP:0000837) | 2.24471510 |
| 78 | Hyperammonemia (HP:0001987) | 2.20649042 |
| 79 | Polar cataract (HP:0010696) | 2.20591239 |
| 80 | Hyporeflexia of lower limbs (HP:0002600) | 2.19154270 |
| 81 | Proximal amyotrophy (HP:0007126) | 2.18385773 |
| 82 | Right ventricular cardiomyopathy (HP:0011663) | 2.16516447 |
| 83 | Resting tremor (HP:0002322) | 2.16226992 |
| 84 | Decreased subcutaneous fat (HP:0001002) | 2.15835589 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15829372 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.15829372 |
| 87 | Neck muscle weakness (HP:0000467) | 2.15201632 |
| 88 | Prominent supraorbital ridges (HP:0000336) | 2.14335748 |
| 89 | Abnormal hemoglobin (HP:0011902) | 2.13440177 |
| 90 | Pulmonary artery stenosis (HP:0004415) | 2.12239860 |
| 91 | Slender build (HP:0001533) | 2.12221531 |
| 92 | Mutism (HP:0002300) | 2.10866922 |
| 93 | Ileus (HP:0002595) | 2.09198613 |
| 94 | Gowers sign (HP:0003391) | 2.05934668 |
| 95 | Venous abnormality (HP:0002624) | 2.05343649 |
| 96 | Infantile muscular hypotonia (HP:0008947) | 2.03136038 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 2.01765638 |
| 98 | Abnormality of the lumbar spine (HP:0100712) | 1.99657709 |
| 99 | Rectal prolapse (HP:0002035) | 1.98967130 |
| 100 | Wormian bones (HP:0002645) | 1.98066338 |
| 101 | Polyphagia (HP:0002591) | 1.97799166 |
| 102 | Aortic dissection (HP:0002647) | 1.95878050 |
| 103 | Cortical dysplasia (HP:0002539) | 1.95357425 |
| 104 | Shallow orbits (HP:0000586) | 1.94333839 |
| 105 | Myotonia (HP:0002486) | 1.93895339 |
| 106 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.93402234 |
| 107 | Prolonged bleeding time (HP:0003010) | 1.91497884 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 1.91209215 |
| 109 | Turricephaly (HP:0000262) | 1.90098533 |
| 110 | Esophageal varix (HP:0002040) | 1.88977992 |
| 111 | Megalocornea (HP:0000485) | 1.88814425 |
| 112 | Fused cervical vertebrae (HP:0002949) | 1.85737094 |
| 113 | Aortic aneurysm (HP:0004942) | 1.85108792 |
| 114 | Polygenic inheritance (HP:0010982) | 1.84966946 |
| 115 | Muscle stiffness (HP:0003552) | 1.84394821 |
| 116 | Adactyly (HP:0009776) | 1.83760834 |
| 117 | Atrioventricular block (HP:0001678) | 1.83309085 |
| 118 | Hyperglycemia (HP:0003074) | 1.83257105 |
| 119 | Abnormal glucose tolerance (HP:0001952) | 1.82986100 |
| 120 | Aortic valve stenosis (HP:0001650) | 1.82781202 |
| 121 | Soft skin (HP:0000977) | 1.82602386 |
| 122 | Striae distensae (HP:0001065) | 1.82460533 |
| 123 | Hypercortisolism (HP:0001578) | 1.82111900 |
| 124 | Corneal dystrophy (HP:0001131) | 1.81406021 |
| 125 | Joint hemorrhage (HP:0005261) | 1.80439399 |
| 126 | Mitral valve prolapse (HP:0001634) | 1.80389978 |
| 127 | Toxemia of pregnancy (HP:0100603) | 1.78661812 |
| 128 | Glucose intolerance (HP:0000833) | 1.78265947 |
| 129 | Protrusio acetabuli (HP:0003179) | 1.77783093 |
| 130 | Coxa vara (HP:0002812) | 1.75045831 |
| 131 | Arterial tortuosity (HP:0005116) | 1.72861432 |
| 132 | Abnormality of the periventricular white matter (HP:0002518) | 1.72551044 |
| 133 | Spinal cord lesions (HP:0100561) | 1.71145884 |
| 134 | Syringomyelia (HP:0003396) | 1.71145884 |
| 135 | Steatorrhea (HP:0002570) | 1.70536487 |
| 136 | Enlarged penis (HP:0000040) | 1.68669886 |
| 137 | Coronal craniosynostosis (HP:0004440) | 1.68662783 |
| 138 | Increased mean platelet volume (HP:0011877) | 1.67292423 |
| 139 | Joint stiffness (HP:0001387) | 1.66910388 |
| 140 | * Abnormal eating behavior (HP:0100738) | 1.66225343 |
| 141 | Foot dorsiflexor weakness (HP:0009027) | 1.66030894 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.65418260 |
| 143 | Hepatosplenomegaly (HP:0001433) | 1.65164203 |
| 144 | Easy fatigability (HP:0003388) | 1.64460795 |
| 145 | Hypercalcemia (HP:0003072) | 1.63610321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 6.10670928 |
| 2 | CAMK1D | 6.08929899 |
| 3 | CAMK1G | 4.51084448 |
| 4 | SIK1 | 4.13423458 |
| 5 | BCKDK | 3.77667263 |
| 6 | RIPK1 | 2.96010131 |
| 7 | LMTK2 | 2.72948417 |
| 8 | MST1R | 2.53030127 |
| 9 | TESK1 | 2.50615852 |
| 10 | PDK3 | 2.38834350 |
| 11 | PDK4 | 2.38834350 |
| 12 | ERN1 | 2.04866553 |
| 13 | PRKAA2 | 1.92169349 |
| 14 | FGFR3 | 1.85393150 |
| 15 | MAP3K13 | 1.81774525 |
| 16 | ARAF | 1.80019065 |
| 17 | INSRR | 1.71051192 |
| 18 | FGFR2 | 1.68073635 |
| 19 | MAPK4 | 1.66154249 |
| 20 | PDGFRA | 1.58486345 |
| 21 | PRKD3 | 1.56567900 |
| 22 | RIPK4 | 1.46858323 |
| 23 | FRK | 1.41886620 |
| 24 | ADRBK1 | 1.39123727 |
| 25 | PDK2 | 1.37182438 |
| 26 | CDK9 | 1.34633870 |
| 27 | MOS | 1.33902519 |
| 28 | TIE1 | 1.31990068 |
| 29 | CDK6 | 1.31595569 |
| 30 | KIT | 1.30973326 |
| 31 | EPHB2 | 1.23919033 |
| 32 | FES | 1.20430234 |
| 33 | MAP3K6 | 1.19242486 |
| 34 | STK38L | 1.18626676 |
| 35 | DDR2 | 1.13954003 |
| 36 | JAK1 | 1.13047716 |
| 37 | IRAK3 | 1.12301254 |
| 38 | TGFBR2 | 1.12060865 |
| 39 | TTN | 1.11004761 |
| 40 | MET | 1.10236360 |
| 41 | KDR | 1.09136056 |
| 42 | PIK3CA | 1.08102411 |
| 43 | NEK9 | 1.08009299 |
| 44 | MAP2K1 | 1.06875538 |
| 45 | PKN1 | 1.03262545 |
| 46 | PRKCH | 1.02985176 |
| 47 | EPHA3 | 1.02973034 |
| 48 | PHKG1 | 1.00818480 |
| 49 | PHKG2 | 1.00818480 |
| 50 | PTK2B | 0.99072649 |
| 51 | PDPK1 | 0.96371430 |
| 52 | LATS1 | 0.93194333 |
| 53 | NLK | 0.92107030 |
| 54 | PRKG1 | 0.90869474 |
| 55 | FER | 0.89680171 |
| 56 | JAK2 | 0.88719567 |
| 57 | FGFR4 | 0.88108227 |
| 58 | PRKAA1 | 0.88076583 |
| 59 | TYK2 | 0.84653058 |
| 60 | GRK1 | 0.81771459 |
| 61 | MYLK | 0.78932445 |
| 62 | PDK1 | 0.75255076 |
| 63 | IGF1R | 0.72574917 |
| 64 | MAPK7 | 0.72431743 |
| 65 | PDGFRB | 0.71841889 |
| 66 | MTOR | 0.71169897 |
| 67 | PRKACG | 0.69813743 |
| 68 | RET | 0.69546580 |
| 69 | LATS2 | 0.68379219 |
| 70 | CAMKK2 | 0.67386090 |
| 71 | CDC42BPA | 0.67030676 |
| 72 | ILK | 0.65975572 |
| 73 | PRKG2 | 0.63896611 |
| 74 | GSK3A | 0.62892589 |
| 75 | PAK2 | 0.60119845 |
| 76 | MARK1 | 0.59171563 |
| 77 | CSK | 0.58890668 |
| 78 | PRKD1 | 0.57886778 |
| 79 | PRKACB | 0.56206637 |
| 80 | INSR | 0.55108723 |
| 81 | MAPKAPK5 | 0.54868921 |
| 82 | FGFR1 | 0.54753993 |
| 83 | DAPK2 | 0.54155125 |
| 84 | MAPK3 | 0.53464470 |
| 85 | MAP2K3 | 0.51592392 |
| 86 | PTK2 | 0.48708327 |
| 87 | PINK1 | 0.47472191 |
| 88 | CAMK1 | 0.47136248 |
| 89 | MAPK11 | 0.46249013 |
| 90 | CDK4 | 0.46096747 |
| 91 | SRC | 0.45862378 |
| 92 | DAPK3 | 0.45139978 |
| 93 | YES1 | 0.44853502 |
| 94 | MAP3K9 | 0.43656023 |
| 95 | CSF1R | 0.43012091 |
| 96 | BMX | 0.42449968 |
| 97 | MARK2 | 0.42161255 |
| 98 | PKN2 | 0.41352854 |
| 99 | RPS6KB1 | 0.40998001 |
| 100 | ABL2 | 0.40884946 |
| 101 | BLK | 0.40513615 |
| 102 | EPHB1 | 0.40429825 |
| 103 | PRKD2 | 0.40259437 |
| 104 | TBK1 | 0.39910914 |
| 105 | JAK3 | 0.38142821 |
| 106 | MAPK12 | 0.38054244 |
| 107 | PRKACA | 0.36930137 |
| 108 | MAP2K4 | 0.36535380 |
| 109 | TGFBR1 | 0.34355054 |
| 110 | EIF2AK2 | 0.34225867 |
| 111 | EEF2K | 0.34171993 |
| 112 | AKT2 | 0.33888623 |
| 113 | MAP3K7 | 0.33016729 |
| 114 | TNK2 | 0.32869948 |
| 115 | STK3 | 0.32380208 |
| 116 | NTRK1 | 0.31746776 |
| 117 | PTK6 | 0.31099246 |
| 118 | ICK | 0.30897837 |
| 119 | ABL1 | 0.30374354 |
| 120 | CAMKK1 | 0.29555664 |
| 121 | MAPK1 | 0.26717816 |
| 122 | STK11 | 0.25852207 |
| 123 | TRPM7 | 0.25600850 |
| 124 | TYRO3 | 0.25504837 |
| 125 | LRRK2 | 0.25378210 |
| 126 | PAK6 | 0.24975844 |
| 127 | PRKCE | 0.24615001 |
| 128 | CDK5 | 0.24154633 |
| 129 | RPS6KA3 | 0.23887141 |
| 130 | MAPKAPK3 | 0.23072132 |
| 131 | MAP3K3 | 0.22421209 |
| 132 | GRK5 | 0.22032130 |
| 133 | MAP3K2 | 0.21668949 |
| 134 | AKT1 | 0.20060319 |
| 135 | SGK3 | 0.19647426 |
| 136 | KSR2 | 0.19257188 |
| 137 | STK38 | 0.18262429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 5.08404618 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.92203161 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.49000420 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.11069947 |
| 5 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.39368182 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.29194753 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.27022401 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.01939268 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71494816 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.52531115 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.27886390 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.08574442 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.98402052 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95513260 |
| 15 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.91430683 |
| 16 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.85910837 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80135549 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79313098 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63394680 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61247271 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.60327265 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56136012 |
| 23 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.52505410 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39852633 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39732104 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.36593365 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26295477 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.26006533 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21198444 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14459342 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12711099 |
| 32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03240903 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.00820796 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00543567 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99459051 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.96334382 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93726143 |
| 38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92415432 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87971609 |
| 40 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86566547 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83955189 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81217334 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81102983 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79296321 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78626708 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77079650 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.76377323 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69384936 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68156673 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 0.64027579 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62438319 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61927533 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60671204 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60648266 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59058678 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58751167 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57859372 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57220676 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56427247 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53023595 |
| 61 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51717426 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45799524 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45448765 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44485651 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.44003293 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43561989 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41786129 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41705423 |
| 69 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41148596 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.39687843 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35127027 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34973893 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34776167 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34199989 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33602145 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33419814 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32433601 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.32156236 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32139023 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32022942 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.29820596 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29313955 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27801081 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27774965 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27428349 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25409838 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25177929 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24761443 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24228802 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.24149577 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21951007 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21199559 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.21102638 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.20838120 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20746686 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19699726 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19395234 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19285324 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.19183280 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19180974 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19168095 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.18978757 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.18403055 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18060620 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.16813292 |
| 106 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.16755070 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15947271 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15761434 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15750347 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.14787786 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14014760 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13365868 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13062672 |
| 114 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.12823257 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.12752184 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.12001934 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.11812540 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.11680152 |
| 119 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11558439 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.10502903 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.09819758 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.09648340 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.09427331 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.09136439 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08504430 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.08041213 |
| 127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08007208 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07227324 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.06816454 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.06671956 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.06529163 |
| 132 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.06524493 |

